4//SEC Filing
Walker Karen Marie 4
Accession 0000950170-24-071493
CIK 0001994702other
Filed
Jun 9, 8:00 PM ET
Accepted
Jun 10, 6:56 PM ET
Size
6.8 KB
Accession
0000950170-24-071493
Insider Transaction Report
Form 4
Walker Karen Marie
Chief Technology Officer
Transactions
- Exercise/Conversion
Common Stock
2024-06-06$4.42/sh+9,636$42,591→ 9,636 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-06-06−9,636→ 82,648 totalExercise: $4.42→ Common Stock (9,636 underlying)
Footnotes (1)
- [F1]25% of the original number of shares subject to the option vested on September 13, 2022, and 1/48th of the original number of shares subject to the option vested or shall vest in monthly installments thereafter.
Documents
Issuer
Kyverna Therapeutics, Inc.
CIK 0001994702
Entity typeother
Related Parties
1- filerCIK 0002008556
Filing Metadata
- Form type
- 4
- Filed
- Jun 9, 8:00 PM ET
- Accepted
- Jun 10, 6:56 PM ET
- Size
- 6.8 KB